Gastric mucosa as a target of persistent proinflammatory aggression: pathogenic models of chronic gastritis;La mucosa gástrica como estructura diana de agresiones proinflamatorias persistentes: modelos patogénicos de gastritis crónica

Gastroenterologia y Hepatologia

Volumn 32, Issue 4, 2009, Pages 294-306

  Sánchez Fayos Calabuig, Paloma ^a   Martín Relloso, M Jesús ^a   Porres Cubero, Juan Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Autoimmune chronic gastritis; Chronic gastritis; Helicobacter pylori; NSAIDs

Indexed keywords

ARTICLE; ATROPHIC GASTRITIS; CELLULAR IMMUNITY; CHRONIC GASTRITIS; EOSINOPHILIC GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMORAL IMMUNITY; NONHUMAN; STOMACH MUCOSA;

CHRONIC DISEASE; EOSINOPHILIA; GASTRIC MUCOSA; GASTRITIS; HUMANS; MODELS, BIOLOGICAL;

EID: 67349134218     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2008.05.004     Document Type: Article

References (83)

1. Lee EL, Feldman M. Gastritis and other gastropathies. En: Sleisenger, Fordstran, editores. Gastrointestinal and liver disease. 7th ed. p. 810-27.
2. a ed., Madrid: McGraw-Hill-Interamericana; 1995. p. 1926.
3. Correa P. Chronic gastritis: a clinico-pathologic classification. Am J Gastroenterol 83 (1988) 504-509
4. Price A.B. The Sydney system: histological division. J Gastroenterol Hepatol 6 (1991) 209-222
5. Dixon M.F., Genta R.M., Yaedley J.H., and Correa P. Classification and grading of gastritis: the update Sydney system. Am J Sug Pathol 20 (1996) 1161-1181
6. Wyatt J.I., and Dixon M.F. Chronic gastritis: a pathogenic approach. J Pathol 154 (1988) 113-124
7. a ed. Madrid: Mosby/Doyma Libros; 1995. p. 71-9.
8. Devenport H.W., Warner H.A., and Code C.F. Functional significance of gastric mucosal barrier. Gastroenterology 47 (1964) 142-152
9. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 (2002) 1175-1186
10. Makola D., Peura D.A., and Croew S.E. Helicobacter pylori infection and related gastroinestinal disease. J Clin Gastroenterol 41 (2007) 548-558
11. Warren J.R., and Marshall B.J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1 (1983) 1273-1275
12. Marshall B.J., and Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (1984) 1311-1315
13. Marshall B.J., Armstrong J.A., McGechie D.B., and Glanzy R.J. Attempt to fulfill Koch's postulate for pylori campilobacter. Med J Aust 142 (1984) 436-439
14. Sipponen P. Update on pathologic approach to the diagnosis of gastritis, gastric atrophy and Helicobacter pylori and its sequelae. J Clin Gastoenterol 32 (2001) 196-202
15. Correa P. Human gastric carcinogenesis: a multistep and mutifactorial process. Cancer Res 52 (1992) 6735-6740
16. Isaacson P.G., and Spencer J. Is gastric lymphoma an infectious disease?. Hum Pathol 24 (1993) 569-570
17. Isaacson P.G. Gastrointestinal lymphoma. Human Pathol 25 (1994) 1020-1029
18. Wotherspoon A.C., Ortiz-Hidalgo C., Falzon M.P., and Isaacson P.G. Helicobacter pylori: associated gastritis and primary B-cell gastric lymphoma. Lancet 339 (1991) 1175-1176
19. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomas, liverflukers and Helicobacter pylori (1994), International Agency for Research on Cancer, Lyon
20. Goodwin C.S., and Worsley B.W. Microbiology of Helicobacter pylori. Gastroenterol Clin North Am 22 (1993) 5-19
21. Cave D.R. Transmission and epidemiology of Helicobacter pylori. Am J Med 100 (1996) 12-17
22. Clyne M., Dolan B., and Reeves E.P. Bacterial factors that mediate colonization on the stomach and virulence of Helicobacter pylori. FEMS Microbiol Lett 268 (2007) 135-143
23. Israel D.A., and Peek R.M. Pathogenesis of Helicobacter pylori: induced gastric inflamation. Aliment Pharmacol Ther 15 (2001) 1271-1290
24. Kusters J.G., Van Vliet A.H., and Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19 (2006) 449-490
25. Radosz-Komniewska H., Bek T., Jozwiak J., and Martinosian G. Pathogenicity of Helicobacter pylori infection. Clin Microbiol Infect 11 (2005) 602-610
26. Yamakoa Y., El-Zimaity H.M., and Gutiérrez O. Relationship between the cagA 3'repeat region of Helicobacter pylori, gastric histology and susceptibility to low pH. Gastroenterology 117 (1999) 342-351
27. Cover T.L., Glupczynski Y., Lage A.P., et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 33 (1995) 1496-1500
28. Israel D.A., and Peek R.M. The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol 22 (2006) 3-7
29. Rautelin H., Sipponen P., and Seppala K. Gastric inflamation and neutrofil-activating and citotoxin-producing Helicobacter pylori strain. Scan J Gastroenterol 31 (1996) 639-648
30. Suárez G., Reyes V.E., and Beswick E.J. Immune response to H. pylori. World J Gastroenterol 12 (2006) 5593-5598
31. Portal-Cellhay C., and Pérez Pérez G.I. Immune responses to helicobacter pylori colonization: mechanisms and clinical outcome. Clin Sci 110 (2006) 305-314
32. Algood H.M.S., and Cover T.L. Helicobacter pylori persistence: an overwiew of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 19 (2006) 597-606
33. Genta R.M., Hammer H.W., and Graham D.Y. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, response to triple therapy. Hum Pathol 24 (1993) 577-583
34. Presotto F., Sabini B., Cecchetto A., Plebani M., De Lazzari F., Pedini B., et al. Helicobacter pylori infection and gastric autoinmune disease: is there a link?. Helicobacter 8 (2003) 578-584
35. Annibale B., Marigani M., and Azzoni C. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 2 (1997) 52-59
36. El-Omar E.M., Oien K., El-Nujumi A., Guillen D., Wirtz A., Dahill S., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113 (1997) 15-24
37. Frommer D.J., Carric K.J., Lee A., and Hazell S.L. Acute presentation of Campilobacter pylori gastritis. Am J Gastroenterol 83 (1988) 1168-1170
38. Stemmermann G.N., and Nower H. Gastritis, nitrosamines and gastric cancer. J Clin Gastroenterol 3 Suppl 2 (1981) 23-28
39. Whittingham S, Mackay IR. En: Rose NR, Mackay IR, editors. The autoimmune dsease. Orlando: Academic Press; 1985. p. 243-66.
40. Epstein F.H. Pernicious anemia. N Engl J Med 337 (1997) 1441-1448
41. Scalabrino G., and Peracchi M. New insights into the pathophysiology of cobalamin deficiency. Trends in Molecular Medicine 12 (2006) 247-254
42. Casthe W.B. Development of knowldge concerning the gastric intrinsic factor and its relation to pernicious anemia. N Engl J Med 249 (1953) 603-614
43. Castle WB. The conquest of pernicious anemia. En: Wintrobe MM, editors. Blood, pure and eloquent. New York: McGraw-Hill; 1980. p. 283.
44. Taylor K.B. Inhibition of intrinsic factor by pernicious anaemia sera. Lancet 2 (1959) 106-108
45. Taylor K.B., Roitt J.M., Domiach D., Couchman K.G., and Shapland C. Autoimmune phenomena in pernicious anaemia: gastric antibodies. BMJ 2 (1962) 1347-1352
46. Carmel R., and Johnson C.S. Racial patterns in pernicious anemia. N Engl J Med 298 (1978) 647-650
47. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Int Med 156 (1996) 1097-1100
48. Delva P.L., MacDonell J.E., and MacIntosh O.C. Megaloblastic anemia accurring simultaneously in white female monozygotic twins. Can Med Asoc J 92 (1965) 1129-1131
49. Gleeson P.A., and Toh B.H. Molecular targets in pernicious anaemia. Immunol Today 12 (1991) 233-238
50. Asano M., Toda M., Sakaguchi M., and Sakaguchi S. Autoinmune desease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184 (1996) 387-396
51. + adenosine triphosphatase of the stomach. J Clin Invest 81 (1988) 475-479
52. De Aizpurua H.J., Cosgrove L.J., Ungar B., and Toh B.H. Autoantibodies cytotoxic to gastric parietal cells in serum of patients with pernicious anemia. N Engl J Med 309 (1983) 625-629
53. De Aizpurua H.J., Toh B.H., and Ungar B. Parietal cell surface reactive autoantibody in pernicious anemia demostrated by indirect immunofluorescence. Clin Exp Immunol 52 (1983) 341-349
54. Barrett S.P., Toh B.H., Alderuccio F., Vam Driel I.R., and Gleeson P.A. Organ-specific autoimmunity induced in adult thymectomy and cyclophosphamide-induced lymphopenia. Eur J Immunol 25 (1995) 238-244
55. Barrett S.P., Gleeson P.A., De Silva H., Toh B.H., and Van Driel I.R. Interferon γ is required during the initiation of an organ-specific autoimmune disease. Eur J Immunol 26 (1996) 1652-1655
56. Bonomo A., Kehn P.J., and Shevach E.M. Post-thymectomy autoimmunity: abnormal T/cell homeostasis. Immunol Today 16 (1995) 61-67
57. Gleeson P.A., Toh B.H., and Van Driel I.R. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 149 (1996) 97-125
58. Kojima A., and Prehn R.T. Genetic susceptibility to post-thymectomy autoimmune disease in mice. Immunogenetics 14 (1981) 15-27
59. Martinelli T.M., Van Driel I.R., Alderuccio F., and Toh B.H. Analysis of mononuclear cell infiltrate and cytokine production in murine autoimmune gastritis. Gastroenterology 110 (1996) 1791-1802
60. Suri-Payer F., Kehn P.J., Cheever A.W., and Shevach E.M. Pathogenesis of post-thymentomy autoinmune gastritis: identification of anti-H/K adenosine triphosphatase reactive T/cells. J Immunol 157 (1996) 1799-1805
61. Brendt R.C., Jewell L.D., and Schuitka T.K. Multicentric gastric carcinoids complicating pernicious anemia. Arch Pathol Lab Med 113 (1989) 399-412
62. Ikeda T., Senove I., and Hara M. Gastric pseudopolyposis: a new clinical manifestation of type A gastritis. Am J Gastroenterol 80 (1985) 82-90
63. Schafer L.W., Larson D.E., and Melton L.J. Risk of development of gastric carcinoma in patients with pernicious anemia: a populations-based study in Rochester, Minnesota. Mayo Clin Proc 60 (1985) 444-461
64. Sculco D., and Bilgrami S. Pernicious anemia and gastric carcinoid tumor: case report and review. Am J Gastroenterol 92 (1997) 1378-1391
65. Arnold R., Hulst M.V., Neuhof C.H., Schwarting H., Beker H.D., and Creutzfeldt W. Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut 23 (1982) 285-291
66. Hsing A.W., Hansson L.E., and McLaughein J.K. Pernicious anemia and subsequent cancer: a population-based cohort study. Cancer 71 (1993) 745-750
67. Sánchez Fayos P., Martín M.J., González A., and Porres J.C. Tumores Carcinoides gastrointestinales: biología celular, expresión molecular y consecuencias fisiopatológicas de una neoplasia enigmática. Gastroenterol Hepatol 31 (2008) 120-129
68. Ectors N.L., Dixon M.F., Geboes K.J., Rutgurts P.J., Desmet V.J., and Vantrappen G.R. Granulomatous gastritis: a morphological and diagnostic approach. Hsitopathology 23 (1993) 55-61
69. Shapiro J.L., Goldblum J.R., and Petras R.A. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an «idiopathic» granolomatous gastritis. Am J Surg Pathol 20 (1996) 462-470
70. Genta RM. Granulomatous gastritis. En: Graham DY, Genta RM, Dixon MF, editors. Gastritis. Philadelphia: Lippicott Williams and Wilkins; 1999. p. 119.
71. Haot J., Hamichi L., Wallez L., and Meinguet P. Lymphocytic gastritis, a newly described entity: a retrospective endoscopic and histological study. Gut 29 (1988) 1258-1264
72. Haot J., Berger F., and Lambert R. Lymphocytic gastritis versus varioliform gastritis: a historical series revisited. J Pathol 158 (1989) 19-22
73. De Giacomo C., Glanatti A., and Negrini R. Lymphocytic gastritis: a positive relationship with celiac disease. J Pediat 124 (1994) 57-62
74. a ed; 2003. p. 217-26.
75. Rothenberg M.E. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol 113 (2004) 11-28
76. Sánchez Fayos P., Martin M.J., and Porres J.C. La esofagogastroenteritis eosinofílicas dentro del espectro de las alergias alimentarias. Rev Clin Esp 206 (2006) 236-238
77. Rothenberg M.E., Mishra A., Brandt E.B., and Hogan S.P. Gastrointestinal eosinophils. Immunol Rev 179 (2001) 139-155
78. Sánchez Fayos P., Martín M.J., González A., and Porres J.C. Los granulocitos eosinófilos: de residentes habituales de la mucosa gastrointestinal normal a protagonistas agresivos de la gastroenteritis eosinofílica. Gastroenterol Hepatol 29 (2006) 352-357
79. Dixon M.F., O'Connor H.J., and Axon A.T. Reflux gastritis. Distinct histopathologic entity?. J Clin Pathol 39 (1986) 524-530
80. Lanas A.I. Antiinflamatorios no esteroideos y patología gastrointestinal. Gastroenterol Hepatol 18 (1995) 142-152
81. Wallace J. Nonesteroideal anti-inflamatory drugs and gastropathy: the second hundreds years. Gastroenterology 112 (1997) 1100-1106
82. Guarner F. Mecanismos de la toxicidad directa de los AINE. Gastroenterol Hepatol 21 (1998) 2-8
83. Wolfe M.M., Lichtenstein D.R., and Singh G. Gastrointestinal toxicity drugs. N Engl J Med 340 (1999) 1888-1899